用于免疫介导疾病的细胞疗法
Natalia Wiewiórska-Krata1,2, Bartosz Foroncewicz2,3, Krzysztof Mucha2,3,4
1Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
Frontiers in medicine
|April 10, 2025
概括
新的细胞疗法,包括造血干细胞 (HSC) 和CAR T细胞,为免疫介导疾病提供了有希望的个性化治疗方法. 这些活药物旨在安全有效地重新平衡免疫系统,可能导致持久的缓解.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞疗法细胞疗法
- 基因工程是一种基因工程.
背景情况:
- 免疫介导疾病在全球范围内日益增加,这给诊断和治疗带来了挑战.
- 目前的治疗方法往往产生不满意的结果或严重的副作用.
- 新兴的细胞疗法利用基因工程细胞作为"活药".
研究的目的:
- 审查免疫介导疾病的细胞疗法的最新进展.
- 突出针对过度免疫反应的新型治疗方法.
- 讨论基于细胞的治疗对个性化医学的潜力.
主要方法:
- 关于细胞疗法的当前文献的综述.
- 专注于造血干细胞 (HSC),介质干细胞 (MSC),调控性T细胞 (Tregs) 和仿真抗原受体 (CAR) 的T细胞.
- 对免疫失调的治疗潜力的分析.
主要成果:
- 细胞疗法显示出针对免疫介导疾病的有针对性,安全和持久治疗的潜力.
- 这些疗法提供了个性化的方法来重新平衡免疫系统.
- 目前正在探索各种细胞类型的免疫调节能力.
结论:
- 细胞疗法在治疗免疫介导疾病方面取得了重大进展.
- 这些新的治疗方法可以在减轻负担的情况下提供持久的缓解.
- 未来的应用承诺通过先进的免疫系统调节来改善患者的生活质量.
相关概念视频
01:27Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
01:40Cell-mediated Immune Responses
66.3K
Overview
66.3K
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:27Cytotoxic T Cells-mediated Immune Response
740
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
740
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:24T Cell Types and Functions
643
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
643